Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Germ line genetic NBN variation and predisposition to B-cell acute lymphoblastic leukemia in children

Carolin S. Escherich, Wenan Chen, Yizhen Li, Wenjian Yang, Rina Nishii, Zhenhua Li, Elizabeth A. Raetz, Meenakshi Devidas, Gang Wu, Kim E. Nichols, Hiroto Inaba, Ching-Hon Pui, Sima Jeha, Bruce M. Camitta, Eric Larsen, Stephen P. Hunger, Mignon L. Loh, Jun J. Yang

Blood (2024) 143 (22): 2270–2283.

https://doi.org/10.1182/blood.2023023336

Published: 2024

Includes: Supplemental data

Journal Articles

Outcome modeling with CRLF2, IKZF1, JAK , and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group Study

Blood (2012) 119 (15): 3512–3522.

https://doi.org/10.1182/blood-2011-11-394221

Published: 2012

Includes: Supplemental data

Journal Articles

Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group

Blood (2011) 118 (11): 3080–3087.

https://doi.org/10.1182/blood-2011-03-341412

Published: 2011

Includes: Supplemental data

Journal Articles

Effectiveness of high-dose methotrexate in T-cell lymphoblastic leukemia and advanced-stage lymphoblastic lymphoma: a randomized study by the Children's Oncology Group (POG 9404)

Barbara L. Asselin, Meenakshi Devidas, Chenguang Wang, Jeanette Pullen, Michael J. Borowitz, Robert Hutchison, Steven E. Lipshultz, Bruce M. Camitta

Blood (2011) 118 (4): 874–883.

https://doi.org/10.1182/blood-2010-06-292615

Published: 2011

Journal Articles

ARID5B Genetic Polymorphisms Contribute to Racial Disparities In Childhood Acute Lymphoblastic Leukemia: A Children's Oncology Group Study

Jun Yang, PhD, Heng Xu, PhD, Cheng Cheng, Ph.D., Meenakshi Devidas, PhD, Deqing Pei, Yiping Fan, PhD, Wenjian Yang, PhD, Geoffrey A. Neale, PhD, Naomi J. Winick, MD, Paul L Martin, MD, PhD, Cheryl L. Willman, MD, Bruce M. Camitta, MD, Gregory H. Reaman, PhD, William L. Carroll, PhD, Mignon Loh, MD, Stephen P. Hunger, MD, William E. Evans, PharmD, Mary V. Relling, PharmD

Blood (2010) 116 (21): 8.

https://doi.org/10.1182/blood.V116.21.8.8

Published: 2010

Journal Articles

Down syndrome childhood acute lymphoblastic leukemia has a unique spectrum of sentinel cytogenetic lesions that influences treatment outcome: a report from the Children's Oncology Group

Kelly W. Maloney, William L. Carroll, Andrew J. Carroll, Meenakshi Devidas, Michael J. Borowitz, Paul L. Martin, Jeanette Pullen, James A. Whitlock, Cheryl L. Willman, Naomi J. Winick, Bruce M. Camitta, Stephen P. Hunger

Blood (2010) 116 (7): 1045–1050.

https://doi.org/10.1182/blood-2009-07-235291

Published: 2010

Journal Articles

Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1 , Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia

Richard C. Harvey, Charles G. Mullighan, I-Ming Chen, Walker Wharton, Fady M. Mikhail, Andrew J. Carroll, Huining Kang, Wei Liu, Kevin K. Dobbin, Malcolm A. Smith, William L. Carroll, Meenakshi Devidas, W. Paul Bowman, Bruce M. Camitta, Gregory H. Reaman, Stephen P. Hunger, James R. Downing, Cheryl L. Willman

Blood (2010) 115 (26): 5312–5321.

https://doi.org/10.1182/blood-2009-09-245944

Published: 2010

Journal Articles

Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia

Blood (2010) 115 (9): 1850–1857.

https://doi.org/10.1182/blood-2009-10-249128

Published: 2010

Journal Articles

Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia

Blood (2010) 115 (7): 1394–1405.

https://doi.org/10.1182/blood-2009-05-218560

Published: 2010

Includes: Supplemental data

Journal Articles

Specific MLL Partner Genes in Infant Acute Lymphoblastic Leukemia (ALL) Associated with Outcome Are Linked to Age and White Blood Cell Count (WBC) at Diagnosis: A Report On the Children's Oncology Group (COG) P9407 Trial.

Blaine W. Robinson, PhD, Meenakshi Devidas, PhD, Andrew J. Carroll, PhD, Richard C. Harvey, PhD, Nyla A. Heerema, PhD, Cheryl L. Willman, MD, Amanda R. Hudome, Elliot C. Woods, Nancy C. Ballantyne, Gregory H. Reaman, MD, Joanne M. Hilden, MD, Bruce M. Camitta, MD, Naomi J. Winick, MD, William L. Carroll, MD, Stephen P Hunger, MD, Zoann E. Dreyer, MD, Carolyn A. Felix, MD

Blood (2009) 114 (22): 907.

https://doi.org/10.1182/blood.V114.22.907.907

Published: 2009

Journal Articles

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study

Michael J. Borowitz, Meenakshi Devidas, Stephen P. Hunger, W. Paul Bowman, Andrew J. Carroll, William L. Carroll, Stephen Linda, Paul L. Martin, D. Jeanette Pullen, David Viswanatha, Cheryl L. Willman, Naomi Winick, Bruce M. Camitta

Blood (2008) 111 (12): 5477–5485.

https://doi.org/10.1182/blood-2008-01-132837

Published: 2008

Includes: Supplemental data

Journal Articles

Delayed Intensification (DI) Enhances Event-Free Survival (EFS) of Children with B-Precursor Acute Lymphoblastic Leukemia (ALL) Who Received Intensification Therapy with Six Courses of Intravenous Methotrexate (MTX): POG 9904/9905: A Childrens Oncology Group Study (COG).

Naomi Winick, MD, Paul L. Martin, MD, PhD, Meenakshi Devidas, PhD, Jonathan Shuster, PhD, Michael J. Borowitz, MD, PhD, Paul Bowman, MD, Eric Larsen, MD, Jeanette Pullen, MD, Stephen P. Hunger, MD, William L. Carroll, MD, Bruce M. Camitta, MD

Blood (2007) 110 (11): 583.

https://doi.org/10.1182/blood.V110.11.583.583

Published: 2007

Journal Articles

Possible Advantage of Twice-Daily 6-Mercaptopurine Dosing in Children with Acute Lymphoblastic Leukemia (ALL).

Thaddeus Y. Carson, BSE, Beverly A. Bell, MD, Gary Erdmann, PhD, Bruce Bostrom, MD, Bruce M. Camitta, MD, Meenakshi Devidas, PhD

Blood (2007) 110 (11): 851.

https://doi.org/10.1182/blood.V110.11.851.851

Published: 2007

Journal Articles

Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia

Hubert Schrezenmeier, Jakob R. Passweg, Judith C. W. Marsh, Andrea Bacigalupo, Christopher N. Bredeson, Eduardo Bullorsky, Bruce M. Camitta, Richard E. Champlin, Robert Peter Gale, Monika Fuhrer, John P. Klein, Anna Locasciulli, Rosi Oneto, Antonius V. M. B. Schattenberg, Gerard Socie, Mary Eapen

Blood (2007) 110 (4): 1397–1400.

https://doi.org/10.1182/blood-2007-03-081596

Published: 2007

Journal Articles

Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens

Richard E. Champlin, Waleska S. Perez, Jakob R. Passweg, John P. Klein, Bruce M. Camitta, Eliane Gluckman, Christopher N. Bredeson, Mary Eapen, Mary M. Horowitz

Blood (2007) 109 (10): 4582–4585.

https://doi.org/10.1182/blood-2006-10-052308

Published: 2007

Journal Articles

Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG)

Kirk R. Schultz, D. Jeanette Pullen, Harland N. Sather, Jonathan J. Shuster, Meenakshi Devidas, Michael J. Borowitz, Andrew J. Carroll, Nyla A. Heerema, Jeffrey E. Rubnitz, Mignon L. Loh, Elizabeth A. Raetz, Naomi J. Winick, Stephen P. Hunger, William L. Carroll, Paul S. Gaynon, Bruce M. Camitta

Blood (2006) 109 (3): 926–935.

https://doi.org/10.1182/blood-2006-01-024729

Published: 2006

Journal Articles

Colonel Mustard, with the rope, in the ballroom

Bruce M. Camitta

Blood (2006) 108 (3): 785.

https://doi.org/10.1182/blood-2006-05-022616

Published: 2006

Journal Articles

Glucocorticoid resistance: a persistent riddle

Bruce M. Camitta

Blood (2006) 108 (3): 787–788.

https://doi.org/10.1182/blood-2006-05-023788

Published: 2006

Journal Articles

A Report of the Event Free Survival (EFS) for Children with Newly Diagnosed Standard Risk Acute Lymphoblastic Leukemia (ALL) Treated on Pediatric Oncology Group (POG) Protocol 9605.

Beverly A. Bell, MD, Sharon B. Abish, MD, Allen Chauvenet, MD, Joanne Kurtzberg, MD, Jeanette Pullen, MD, Meenakshi Devidas, PhD, Jonathan Shuster, PhD, Bruce M. Camitta, MD

Blood (2005) 106 (11): 875.

https://doi.org/10.1182/blood.V106.11.875.875

Published: 2005

Journal Articles

Thrombotic and Hemorrhagic Events for Patients on Pediatric Oncology Group (POG) Protocols 9201, 9605, 9406.

Megan A. Rice, Beverly A. Bell, MD, Allen Chauvenet, MD, Joanne Kurtzberg, MD, Sharon B. Abish, MD, Jeanette Pullen, MD, Meenakshi Devidas, PhD, Bruce M. Camitta, MD

Blood (2005) 106 (11): 880.

https://doi.org/10.1182/blood.V106.11.880.880

Published: 2005

NARROW

Germ line genetic NBN variation and predisposition to B-cell acute lymphoblastic leukemia in children

Outcome modeling with CRLF2, IKZF1, JAK , and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group Study

Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group

Effectiveness of high-dose methotrexate in T-cell lymphoblastic leukemia and advanced-stage lymphoblastic lymphoma: a randomized study by the Children's Oncology Group (POG 9404)

ARID5B Genetic Polymorphisms Contribute to Racial Disparities In Childhood Acute Lymphoblastic Leukemia: A Children's Oncology Group Study

Down syndrome childhood acute lymphoblastic leukemia has a unique spectrum of sentinel cytogenetic lesions that influences treatment outcome: a report from the Children's Oncology Group

Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1 , Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia

Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia

Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia

Specific MLL Partner Genes in Infant Acute Lymphoblastic Leukemia (ALL) Associated with Outcome Are Linked to Age and White Blood Cell Count (WBC) at Diagnosis: A Report On the Children's Oncology Group (COG) P9407 Trial.

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study

Delayed Intensification (DI) Enhances Event-Free Survival (EFS) of Children with B-Precursor Acute Lymphoblastic Leukemia (ALL) Who Received Intensification Therapy with Six Courses of Intravenous Methotrexate (MTX): POG 9904/9905: A Childrens Oncology Group Study (COG).

Possible Advantage of Twice-Daily 6-Mercaptopurine Dosing in Children with Acute Lymphoblastic Leukemia (ALL).

Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia

Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens

Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG)

Colonel Mustard, with the rope, in the ballroom

Glucocorticoid resistance: a persistent riddle

A Report of the Event Free Survival (EFS) for Children with Newly Diagnosed Standard Risk Acute Lymphoblastic Leukemia (ALL) Treated on Pediatric Oncology Group (POG) Protocol 9605.

Thrombotic and Hemorrhagic Events for Patients on Pediatric Oncology Group (POG) Protocols 9201, 9605, 9406.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only